Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ya, Zhang"'
Publikováno v:
Biomarker Research
Biomarker Research, Vol 9, Iss 1, Pp 1-18 (2021)
Biomarker Research, Vol 9, Iss 1, Pp 1-18 (2021)
B-cell non-Hodgkin lymphoma (B-NHL) is a group of heterogeneous disease which remains incurable despite developments of standard chemotherapy regimens and new therapeutic agents in decades. Some individuals could have promising response to standard t
Autor:
Guanwen Gong, Keshuai Xiao, Zhi-Wei Jiang, Guowei Zhou, Ya Zhang, Xin-Xin Liu, Jiabao Wu, Chaoqun Ma
Publikováno v:
BMC Surgery
Background Liver metastasis (LIM) of gastrointestinal stromal tumor (GIST) is associated with poor prognosis. The present study aimed at developing and validating nomogram to predict LIM in patients with GIST, thus helping clinical diagnosis and trea
Publikováno v:
Biomarker Research
Biomarker Research, Vol 8, Iss 1, Pp 1-11 (2020)
Biomarker Research, Vol 8, Iss 1, Pp 1-11 (2020)
Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia with high heterogeneity in the western world. Thus, investigators identified a number of prognostic biomarkers and scoring systems to guide treatment decisions and validated them
Autor:
Hongzhi Xu, Xiaoming Zhou, Ya Zhang, Xin Wang, Jianhong Wang, Xiangxiang Zhou, Juan Yang, Xiaosheng Fang, Na Chen, Ying Li
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-15 (2020)
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-15 (2020)
Background Hippo-Yes-associated protein (YAP) signaling is a key regulator of organ size and tumorigenesis, yet the underlying molecular mechanism is still poorly understood. At present, the significance of the Hippo-YAP pathway in diffuse large B-ce
Autor:
Zuozhang Yang, Ya Zhang, Yanjin Chen, Lida Shen, Zhaoxin Zhang, Mingyan Ren, Lin Xie, Zhongqin Yuan
Publikováno v:
World Journal of Surgical Oncology
Metastatic spinal tumours are the most common type of bone metastasis. Various methods have been used to treat metastatic spinal lesions, including radiotherapy, chemotherapy, isotope therapy, bisphosphonate therapy, analgesics, and surgery. Conserva
Autor:
Zhigang Zhao, Lei Wang, Chang-yu Pan, Haoming Tian, Hong Li, Linong Ji, Xiang-Ling Wang, Chen Yao, Juming Lu, Qiang Li, Qifu Li, Yong-De Peng, Ru-Ya Zhang
Publikováno v:
Cardiovascular Diabetology
Background and aim Limitations of the currently recommended stepwise treatment pathway for type 2 diabetes mellitus (T2DM), especially the failure of monotherapies to maintain good glycemic control, have prompted use of early, more aggressive combina